Australia markets close in 3 hours 16 minutes

Lexaria Bioscience Corp. (LEXX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.4100+0.2800 (+8.95%)
At close: 04:00PM EDT
3.5000 +0.09 (+2.64%)
After hours: 06:34PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/08/2023
31/08/2022
31/08/2021
31/08/2020
Total revenue
404.726
226.208
255.397
722.738
384.543
Cost of revenue
17.569
31.5
71.841
175.346
99.378
Gross profit
387.157
194.708
183.556
547.392
215.415
Operating expenses
Research development
2,961
3,667
1,843
1,263
387.074
Selling general and administrative
2,748
3,062
4,960
4,971
3,977
Total operating expenses
5,709
6,729
6,803
6,234
4,364
Operating income or loss
-5,322
-6,534
-6,619
-5,687
-4,149
Total other income/expenses net
-180.004
-221.693
-764.614
1,523
-96.331
Income before tax
-5,470
-6,713
-7,384
-4,164
-4,149
Income from continuing operations
-5,470
-6,713
-7,384
-4,164
-4,149
Net income
-5,440
-6,665
-7,269
-4,027
-3,934
Net income available to common shareholders
-5,440
-6,665
-7,269
-4,027
-3,934
Basic EPS
-1.01
-1.01
-1.24
-0.95
-1.47
Diluted EPS
-1.01
-1.01
-1.24
-0.95
-1.47
Basic average shares
6,614
6,614
5,885
4,391
2,773
Diluted average shares
6,614
6,614
5,885
4,391
2,773